Expert Review of Clinical Immunology

Top Research Topics at Expert Review of Clinical Immunology?

The journal is mainly concerned with subjects like Immunology, Disease, Immune system, Internal medicine and Intensive care medicine. Immunology studies presented in it focus on topics such as Inflammation, Autoimmunity, Pathogenesis, Immunotherapy and Antibody. The research on Disease discussed in the journal draws on the closely related field of Dermatology.

The majority of Dermatology studies are focused on the issues of Psoriasis. Innate immune system, Acquired immune system and Immunity are among the concentrations of Immune system that garnered much attention in the journal. The journal explores issues in Internal medicine which can be linked to other research areas like Gastroenterology and Oncology.

The research on Intensive care medicine featured in Expert Review of Clinical Immunology combines topics in other fields like Physical therapy and Asthma. It investigates Asthma research which frequently intersects with Allergy. Rheumatoid arthritis and Arthritis are closely related fields of research discussed in it.

• Immunology (56.72%)
• Disease (20.62%)
• Immune system (14.69%)

What are the most cited papers published in the journal?

• The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases (246 citations)
• Immune responses in neonates (211 citations)
• The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis (196 citations)

Research areas of the most cited articles at Expert Review of Clinical Immunology:

The published papers investigate studies in Immunology, Disease, Immune system, Inflammation and Internal medicine. The most cited publications focus on Immunology research which is adjacent to topics in Intensive care medicine. The Disease research tackled in the most cited articles is interrelated with Epidemiology which concerns subjects like Pediatrics.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Cancer

The previous edition focused in particular on these issues:

Expert Review of Clinical Immunology mostly deals with topics like Immunology, Disease, Internal medicine, Immune system and Intensive care medicine. Expert Review of Clinical Immunology concentrated on Immunology research, specifically Pathogenesis, Inflammation, Autoantibody, Autoimmunity and Antibody. The research on Disease tackled can also make contributions to studies in the areas of stat, Epidemiology, Uveitis and Bioinformatics.

Internal medicine research presented in it encompasses a variety of subjects, including Gastroenterology and Oncology. Expert Review of Clinical Immunology focuses on Immune system but the discussions also offer insight into other areas such as Receptor, PI3K/AKT/mTOR pathway, Neuroscience and Sepsis. The journal explores research in Intensive care medicine alongside concepts in Coronavirus disease 2019 (COVID-19) and other areas of study in Virology, Vaccination and MEDLINE.

The most cited articles from the last journal are:

• Circulating Calprotectin as a Biomarker of COVID-19 Severity. (8 citations)
• A comparative review of immunoassays for COVID-19 detection. (6 citations)
• New frontiers in precision medicine for Sjogren's syndrome. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Expert Review of Clinical Immunology (based on the number of publications) are:

• Nima Rezaei (40 papers) published 3 papers at the last edition the same number as at the previous edition,
• Asghar Aghamohammadi (32 papers) published 1 paper at the last edition, 3 less than at the previous edition,
• Devendra K. Agrawal (25 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Hassan Abolhassani (23 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• Giorgio Walter Canonica (13 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Expert Review of Clinical Immunology (based on the number of publications) are:

• Tehran University of Medical Sciences (53 papers) published 6 papers at the last edition, 1 less than at the previous edition,
• Boston Children's Hospital (30 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• University of Milan (28 papers) published 4 papers at the last edition, 2 more than at the previous edition,
• Mayo Clinic (25 papers) absent at the last edition,
• University of Genoa (25 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 8.11% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 16.67% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.82% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 25.49% of all publications and 49.02% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.